elastin and Urinary-Bladder-Neoplasms

elastin has been researched along with Urinary-Bladder-Neoplasms* in 3 studies

Other Studies

3 other study(ies) available for elastin and Urinary-Bladder-Neoplasms

ArticleYear
Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.
    Oncotarget, 2022, Volume: 13

    Cystoscopic visualization of bladder cancer is an essential method for initial bladder cancer detection and diagnosis, transurethral resection, and monitoring for recurrence. We sought to develop a new intravesical imaging agent that is more specific and sensitive using a polypeptide based NIR (near-infrared) probe designed to detect cells bearing epidermal growth factor receptors (EGFR) that are overexpressed in 80% of urothelial carcinoma (UC) cases. The NIR imaging agent consisted of an elastin like polypeptide (ELP) fused with epidermal growth factor (EGF) and conjugated to Cy5.5 to give Cy5.5-N24-EGF as a NIR contrast agent. In addition to evaluation in human cells and tissues, the agent was tested in canine cell lines and tissue samples with naturally occurring invasive UC. Flow cytometry and confocal microscopy were used to test cell-associated fluorescence of the probe in T24 human UC cells, and in K9TCC-SH (high EGFR expression) and K9TCC-Original (low EGF expression) canine cell lines. The probe specifically engages these cells through EGFR within 15 min of incubation and reached saturation within a clinically relevant 1 h timeframe. Furthermore,

    Topics: Animals; Carbocyanines; Carcinoma, Transitional Cell; Cell Line, Tumor; Contrast Media; Dogs; Elastin; Epidermal Growth Factor; ErbB Receptors; Humans; Mice, Nude; Peptides; Recombinant Fusion Proteins; Urinary Bladder Neoplasms

2022
Transitional cell carcinoma matrix stiffness regulates the osteopontin and YAP expression in recurrent patients.
    Molecular biology reports, 2021, Volume: 48, Issue:5

    Cells translate the mechanosensing of extracellular matrix component dysregulation and stiffness into the signal transduction including Osteopontin (OPN) through the Hippo pathway. But how extracellular matrix (ECM) component dysregulation and stiffness are ultimately linked to transitional cell carcinoma (TCC) development remains poorly understood. This study was aimed to evaluate the possible links between ECM component alteration after cancer surgery and OPN and Yes-associated protein (YAP) expression in TCC and adjacent tissues. In this study, we used 50 TCC (25 newly diagnosed and 25 recurrent) and 50 adjacent tissues to determine the tissue stiffness using atomic force microscopy. The mRNA expression of SPP1, Indian hedgehog (IHH), and YAP was also determined using qRT-PCR. Western blotting and ELISA were performed to assess the tissue and serum levels of OPN, respectively. To assess the glycoproteins and elastic fibers content, Periodic Acid Schiff, and Verhoeff-Van Gieson Staining were performed, respectively. Matrix stiffness was markedly higher in TCCs than adjacent tissues (p < 0.05). Gene expression analysis showed that YAP, SPP1, and IHH genes were upregulated in TCC tissues (p < 0.05). Additionally, the OPN protein overexpression was observed in the tissue and the serum of TCC patients (p < 0.05). We also found that glycoproteins, elastic fibers content of recurrent TCC tissues was remarkably higher as compared to adjacent tissues (p < 0.05). Our results suggest that glycoproteins and elastic fibers content modulation and ECM stiffness may upregulates the expression of YAP, SPP1 and IHH genes, and possibly contribute to the TCC development and relapse.

    Topics: Aged; Carcinoma, Transitional Cell; Case-Control Studies; Elastin; Extracellular Matrix; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Hippo Signaling Pathway; Humans; Male; Neoplasm Recurrence, Local; Osteopontin; Proteoglycans; Up-Regulation; Urinary Bladder Neoplasms; YAP-Signaling Proteins

2021
Application of Bld-1-Embedded Elastin-Like Polypeptides in Tumor Targeting.
    Scientific reports, 2018, 03-01, Volume: 8, Issue:1

    Expression of various molecules on the surface of cancer cells compared to normal cells creates a platform for the generation of various drug vehicles for targeted therapy. Multiple interactions between ligands and their receptors mediated by targeting peptide-modified polymer could enable simultaneous delivery of a drug selectively to target tumor cells, thus limiting side effects resulting from non-specific drug delivery. In this study, we synthesized a novel tumor targeting system by using two key elements: (1) Bld-1 peptide (SNRDARRC), a recently reported bladder tumor targeting peptide identified by using a phage-displayed peptide library, and (2) ELP, a thermally responsive polypeptide. B

    Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Elastin; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Peptides; Protein Binding; Urinary Bladder Neoplasms

2018